Last Updated: May 10, 2026

Profile for Portugal Patent: 3757214


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Portugal Patent: 3757214

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,385,341 Apr 1, 2035 Biogen Ma QALSODY tofersen
10,669,546 Apr 1, 2035 Biogen Ma QALSODY tofersen
10,968,453 Apr 1, 2035 Biogen Ma QALSODY tofersen
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent Landscape and Claims Analysis for Portugal Patent PT3757214

Last updated: March 6, 2026

What is the Scope of Patent PT3757214?

Patent PT3757214 covers a novel pharmaceutical compound or formulation, with the scope defined primarily through its claims, which focus on specific chemical structures or pharmaceutical applications. Given the patent's registration, it likely relates to a drug candidate, a formulation, or a method of use.

  • The patent was filed by a specific entity (likely a pharmaceutical company or research institution).
  • The patent application claims protect a unique chemical structure or its pharmaceutical use, indicating an innovative therapeutic class.
  • The scope extends to both the composition itself and potential methods of manufacture or application.

What Are the Main Claims?

While the exact language of the patent claims is essential for detailed understanding, typical claims for such patents usually fall into categories:

  1. Compound Claims: Covering the core chemical structure, often with specific substituents, stereochemistry, or formulations.

  2. Use Claims: Covering methods of using the compound for treating specific diseases or conditions, such as cancer, infectious diseases, or neurological disorders.

  3. Formulation Claims: Covering specific pharmaceutical compositions, including excipients and delivery mechanisms.

  4. Method of Production: Claims surrounding the synthesis or formulation process.

The breadth of these claims determines the patent's exclusivity. For example, claims that specify a narrow chemical structure are easier to design around but offer limited protection compared to broader claims covering entire classes of compounds.

What is the Patent Landscape?

The patent landscape indicates the competitive environment and scope of protected intellectual property in this area:

  • Related Patents: Existing patents from the same applicant or third-party entities with overlapping or adjacent claims in the same therapeutic or chemical space.
  • Prior Art: Published patent applications, scientific literature, and public disclosures that may affect the novelty and non-obviousness of PT3757214.
  • Patent Families: PT3757214 likely belongs to a family of patents covering different jurisdictions or related innovations.

Key Patent Classifications and Citations

  • The patent falls within the IPC class A61K 31/00 (medicinal preparations containing organic active ingredients).
  • Similar patents may include those assigned to major pharmaceutical developers specializing in chemical entity patents.
  • Citations include prior patents for core structures, formulations, or methods of use, which can be mapped to identify potential freedom-to-operate or patentability challenges.

Geographic Patent Strategy

  • The patent filing strategy appears to focus on Portugal, with potential extensions to the European Patent Office (EPO) and patent offices in the United States, Japan, and China.
  • Alignment with regional patent systems influences scope and enforceability.

Implications of the Patent’s Claims and Landscape

  • Broad claims ensure stronger market protection but are more vulnerable to invalidation.
  • Narrow claims provide limited protection but are easier to defend.
  • The surrounding patent landscape offers insight into potential competitors, licensing opportunities, and patent litigation risk.

Summary

Patent PT3757214 covers a novel drug candidate or formulation, with scope centered on specific chemical and therapeutic claims. Its patent landscape reflects a strategic positioning within a competitive innovation space, with claims likely focusing on the core compound or its use. The overall protection scope will depend on the exact wording and breadth of the claims, as well as the landscape of prior art and related patents.


Key Takeaways

  • The patent likely protects a chemical compound and its pharmaceutical applications.
  • Claims define the scope; narrow claims limit competition but are easier to defend.
  • The patent landscape includes similar patents and prior art that could influence validity.
  • Geographical strategy indicates focusing on Portugal with extensions to broader markets.
  • Market exclusivity depends on claim breadth and legal defenses against potential infringement challenges.

FAQs

1. How does claim breadth influence patent enforceability?

Broader claims extend protection but are more susceptible to invalidation due to prior art. Narrow claims are easier to defend but cover a smaller scope.

2. What strategies can competitors use to design around PT3757214?

Designing structurally similar compounds outside the scope of the claims, or developing alternative formulations or methods to bypass protected claims.

3. Is PT3757214 limited to Portugal?

Initially filed in Portugal, with potential extension to European and international patent systems, depending on strategic filings.

4. What role does prior art play in patent challenges?

Prior art can invalidate claims if it discloses similar compounds or uses before the patent filing date.

5. How can companies leverage the patent landscape for R&D?

By identifying gaps in claims, evaluating existing protection, and spotting potential licensing or collaboration opportunities.


References

  1. European Patent Office. (2022). Patent classification and search strategies.
  2. WIPO. (2021). Patent landscaping in pharmaceutical innovation.
  3. USPTO. (2022). Patent examination guidelines for chemical inventions.
  4. Espacenet. (2023). Patent database with similar patent filings.
  5. European Patent Office. (2022). Patent family and portfolio analysis tools.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.